Edition:
India

AzurRx BioPharma Inc (AZRX.OQ)

AZRX.OQ on NASDAQ Stock Exchange Capital Market

2.76USD
17 Jul 2018
Change (% chg)

$-0.07 (-2.47%)
Prev Close
$2.83
Open
$2.83
Day's High
$2.85
Day's Low
$2.75
Volume
5,478
Avg. Vol
9,687
52-wk High
$5.25
52-wk Low
$2.25

Latest Key Developments (Source: Significant Developments)

Azurrx Biopharma Files For Mixed Shelf Of Up To $50 Million - SEC Filing
Wednesday, 4 Jul 2018 

July 3 (Reuters) - AzurRx BioPharma Inc ::AZURRX BIOPHARMA FILES FOR MIXED SHELF OF UP TO $50 MILLION - SEC FILING.  Full Article

Laurence W Lytton Reports 6.15 Pct Passive Stake In Azurrx Biopharma As Of May 1
Saturday, 12 May 2018 

May 11 (Reuters) - AzurRx BioPharma Inc ::LAURENCE W LYTTON REPORTS 6.15 PERCENT PASSIVE STAKE IN AZURRX BIOPHARMA INC AS OF MAY 1 - SEC FILING.  Full Article

AzurRx BioPharma Announces Receipt of Required Approvals to Add French Clinical Site for its Phase IIa Study of MS1819-SD
Thursday, 18 Jan 2018 

Jan 18 (Reuters) - Azurrx Biopharma Inc ::AZURRX BIOPHARMA ANNOUNCES RECEIPT OF REQUIRED APPROVALS TO ADD FRENCH CLINICAL SITE FOR ITS PHASE IIA STUDY OF MS1819-SD FOR EXOCRINE PANCREATIC INSUFFICIENCY.AZURRX BIOPHARMA INC - IN PARTNERSHIP WITH MAYOLY SPINDLER, RECEIVED REQUIRED APPROVALS TO ADD A FRENCH SITE TO PHASE IIA STUDY OF MS1819-SD.  Full Article

AzurRx Biopharma files for mixed shelf offering of up to $10 mln
Thursday, 2 Nov 2017 

Nov 1 (Reuters) - AzurRx Biopharma Inc :AzurRx Biopharma Inc files for mixed shelf offering of up to $10 million - SEC filing‍​.  Full Article

Azurrx Biopharma, Mayoly Spindler announce IMPD submission
Friday, 20 Oct 2017 

Oct 20 (Reuters) - Azurrx Biopharma Inc ::Azurrx Biopharma and Mayoly Spindler announce MS1819-SD investigational medicinal product dossier (IMPD) submission.Azurrx Biopharma - ‍IMPD submitted via European Medicines Agency clinical trial portal for approval prior to opening of clinical centers in France.  Full Article

AzurRx BioPharma files for stock shelf of upto $10 mln
Thursday, 12 Oct 2017 

Oct 11 (Reuters) - Azurrx Biopharma Inc :Azurrx biopharma inc files for stock shelf of upto $10 million - sec filing‍​‍​.  Full Article

Azurrx Biopharma reports pricing of IPO
Wednesday, 12 Oct 2016 

Azurrx Biopharma Inc :Says initial public offering of 960,000 common shares priced at $5.50 per share.  Full Article

AzurRx Biopharma shares open at $5.06 in debut, below IPO price of $5.50/share
Wednesday, 12 Oct 2016 

: AzurRx Biopharma Inc shares open at $5.06 in debut, below IPO price of $5.50 per share Further company coverage: [AZRX.O] ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

Azurrx Biopharma Inc sees IPO of 1.2 mln shares priced at $5.50 per share
Wednesday, 5 Oct 2016 

Azurrx Biopharma Inc :Azurrx Biopharma Inc sees IPO of 1.2 mln shares priced at $5.50 per share, below previously stated range of $6-$8 per share.  Full Article

Azurrx biopharma sees IPO of 1.7 mln shares of its common stock priced between $6.00-$8.00 per share
Tuesday, 6 Sep 2016 

Azurrx Biopharma Inc :Sees IPO of 1.7 million shares of its common stock priced between $6.00 and $8.00 per share - SEC Filing.  Full Article

BRIEF-Azurrx Biopharma Enrolls New Patients For Phase IIA Study Of MS1819-SD

* AZURRX BIOPHARMA ANNOUNCES ENROLLMENT OF THREE NEW PATIENTS FOR ITS PHASE IIA STUDY OF MS1819-SD Source text for Eikon: Further company coverage: